Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01228734
What this trial is testing

A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients

Who this might be right for
Metastatic Colorectal Cancer
Merck KGaA, Darmstadt, Germany 553
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07538258
What this trial is testing

Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Yayi He 27
Large-scale testing (Phase 3)UnknownNCT02604615
What this trial is testing

The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy

Who this might be right for
Stage III Esophageal Squamous Cell CarcinomaEsophageal Neoplasms
The First Affiliated Hospital of Henan University of Science and Technology 60
Testing effectiveness (Phase 2)Looking for participantsNCT06838208
What this trial is testing

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital 56
Large-scale testing (Phase 3)Looking for participantsNCT07414758
What this trial is testing

Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy

Who this might be right for
Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 68
Not applicableLooking for participantsNCT07263178
What this trial is testing

Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Boryung Pharmaceutical Co., Ltd 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06176885
What this trial is testing

Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
yue junhan 36
Large-scale testing (Phase 3)Active Not RecruitingNCT05607550
What this trial is testing

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

Who this might be right for
Metastatic Non-Small Cell Lung CancerAdvanced Non-Small Cell Lung CancerEGFR Exon 20 Mutations
ArriVent BioPharma, Inc. 398
Not applicableStudy completedNCT07445568
What this trial is testing

Home-Based Quadriceps Isometric Exercise for Knee Osteoarthritis Pain

Who this might be right for
Older Adults (60 - 85 Years Old)OA Knee
Universidad del Valle de México, Campus Cuernavaca 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827
What this trial is testing

FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy
Sun Yat-sen University 36
Large-scale testing (Phase 3)Study completedNCT00300586
What this trial is testing

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Hospices Civils de Lyon 842
Testing effectiveness (Phase 2)UnknownNCT02144194
What this trial is testing

Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca

Who this might be right for
Breast Cancer
Cancer Research Group - Collaborative Group, Beirut, Lebanon. 65
Testing effectiveness (Phase 2)WithdrawnNCT02531854
What this trial is testing

Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Advaxis, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT06668961
What this trial is testing

SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line Treatment in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 48
Testing effectiveness (Phase 2)Looking for participantsNCT04144569
What this trial is testing

PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC

Who this might be right for
HER2 Insertion Mutation Positive Advanced NSCLC
Yongchang Zhang 30
Testing effectiveness (Phase 2)Study completedNCT03751761
What this trial is testing

GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study

Who this might be right for
Metastatic Gastric Cancer
Asan Medical Center 58
Not applicableEnded earlyNCT01142869
What this trial is testing

An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Carcinoma, Squamous Cell
Merck KGaA, Darmstadt, Germany 133
Post-approval studies (Phase 4)UnknownNCT02103257
What this trial is testing

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Who this might be right for
EGFR Positive Non-small Cell Lung CancerAdenocarcinoma
Betta Pharmaceuticals Co., Ltd. 192
Large-scale testing (Phase 3)Study completedNCT00790036
What this trial is testing

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Novartis Pharmaceuticals 742
Large-scale testing (Phase 3)Study completedNCT00973609
What this trial is testing

Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

Who this might be right for
Colorectal Neoplasms
AIO-Studien-gGmbH 853
Next Page